Andarine (CAS 401900-40-1)

Andarine (CAS 401900-40-1) References

1. Pharmacokinetics of S-3-(4-acetylamino-phenoxy)-2-hydroxy-2-methyl-N-(4-nitro- 3-trifluoromethyl-phenyl)-propionamide in rats, a non-steroidal selective androgen receptor modulator.  |  Kearbey, JD., et al. 2004. Xenobiotica. 34: 273-80. PMID: 15204699
2. Selective androgen receptor modulator treatment improves muscle strength and body composition and prevents bone loss in orchidectomized rats.  |  Gao, W., et al. 2005. Endocrinology. 146: 4887-97. PMID: 16099859
3. In vivo metabolism and final disposition of a novel nonsteroidal androgen in rats and dogs.  |  Perera, MA., et al. 2006. Drug Metab Dispos. 34: 1713-21. PMID: 16815963
4. Selective Androgen Receptor Modulator (SARM) treatment prevents bone loss and reduces body fat in ovariectomized rats.  |  Kearbey, JD., et al. 2007. Pharm Res. 24: 328-35. PMID: 17063395
5. Detection of the arylpropionamide-derived selective androgen receptor modulator (SARM) S-4 (Andarine) in a black-market product.  |  Thevis, M., et al. 2009. Drug Test Anal. 1: 387-92. PMID: 20355219
6. Effects of a novel selective androgen receptor modulator on dexamethasone-induced and hypogonadism-induced muscle atrophy.  |  Jones, A., et al. 2010. Endocrinology. 151: 3706-19. PMID: 20534726
7. Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator andarine (S-4) for routine doping control purposes.  |  Thevis, M., et al. 2010. Rapid Commun Mass Spectrom. 24: 2245-54. PMID: 20623476
8. Confiscated black market products and nutritional supplements with non-approved ingredients analyzed in the Cologne Doping Control Laboratory 2009.  |  Kohler, M., et al. 2010. Drug Test Anal. 2: 533-7. PMID: 21204286
9. Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator S-22 to identify potential targets for routine doping controls.  |  Thevis, M., et al. 2011. Rapid Commun Mass Spectrom. 25: 2187-95. PMID: 21710598
10. High-throughput screening for various classes of doping agents using a new 'dilute-and-shoot' liquid chromatography-tandem mass spectrometry multi-target approach.  |  Guddat, S., et al. 2011. Drug Test Anal. 3: 836-50. PMID: 22135086
11. Sensitive determination of prohibited drugs in dried blood spots (DBS) for doping controls by means of a benchtop quadrupole/Orbitrap mass spectrometer.  |  Thomas, A., et al. 2012. Anal Bioanal Chem. 403: 1279-89. PMID: 22231507
12. Detection of the selective androgen receptor modulator S-4 (Andarine) in a doping control sample.  |  Starcevic, B., et al. 2013. Drug Test Anal. 5: 377-9. PMID: 23427117
13. Selective androgen receptor modulators: in vitro and in vivo metabolism and analysis.  |  de Rijke, E., et al. 2013. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 30: 1517-26. PMID: 23883284
14. Therapies for musculoskeletal disease: can we treat two birds with one stone?  |  Girgis, CM., et al. 2014. Curr Osteoporos Rep. 12: 142-53. PMID: 24633910
15. Detection of the selective androgen receptor modulator andarine (S-4) in a routine equine blood doping control sample.  |  Cawley, AT., et al. 2016. Drug Test Anal. 8: 257-61. PMID: 26456227